A Brief History of Hypocretin/Orexin and Narcolepsy
Open Access
- 1 November 2001
- journal article
- review article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 25 (5) , S14-S20
- https://doi.org/10.1016/s0893-133x(01)00317-7
Abstract
The hypothalamic peptides named the orexins, or hypocretins, were discovered in 1998. In 1999 it was established that genetic narcolepsy could be caused by mutations in the genes synthesizing these peptides or their receptors. In September of 2000 it was found that most human narcolepsy is caused by loss of hypocretin cells, most likely as a result of a degenerative process. This paper reviews these events and their implications for our understanding of brain arousal and motor control systems.Keywords
This publication has 44 references indexed in Scilit:
- Neuronal Activity in Narcolepsy: Identification of Cataplexy-Related Cells in the Medial MedullaScience, 2006
- NarcolepsyCell, 2004
- Effects of lateral preoptic area application of orexin-A on sleep–wakefulnessNeuroReport, 2000
- Development of Cataplexy in Genetically Narcoleptic DobermansExperimental Neurology, 1998
- The prevalence of narcolepsy: An epidemiological study of the Finnish Twin CohortAnnals of Neurology, 1994
- Rapid-eye movement sleep and muscarinic receptor binding in rats are augmented during withdrawal from chronic scopolamine treatmentLife Sciences, 1986
- Subcortical waking and sleep during lateral hypothalamic “somnolence” in ratsPhysiology & Behavior, 1982
- The Neuropharmacology of Sleep and WakefulnessAnnual Review of Pharmacology and Toxicology, 1978
- Deprivation of rapid eye movement sleep and nesting behavior in ratsPhysiology & Behavior, 1977
- REM Sleep Induction by Physostigmine Infusion During SleepScience, 1976